Safety and Quality Committee
The Safety and Quality Committee works with fellows and ANZCA Council to support safe clinical practice in anaesthesia and pain medicine.
Find out more
Asia-Pacific resources
The Global Development Committee develop and promote resources to support our Asia-Pacific colleagues' continued professional development.
Find out more
Steuart Henderson Award
Awarded to a fellow who has demonstrated excellence and provided outstanding contribution, scholarship, and mentorship to medical education in the field of anaesthesia and/or pain medicine.
Find out more
Pain medicine exams
Find dates and locations of long-case assessments and FPM fellowship exams, as well as information on the format, marking criteria, and application fees and forms.
Find out more
ANZCA CICM Dual Training Pathway FAQs
Everything you need to know about the proposed ANZCA CICM dual training pathway, including the reasons for its development, duration, eligibility requirements and the timeframes.
Find out more
Frequently asked questions about STP
We answered some common questions about the Specialist Training Program.
Find out more
Working and teaching overseas
There are some incredible opportunities to work and teach overseas as an anaesthetist or pain specialist, and make a real difference to global health. If you're interested in joining the ever-growing number of fellows developing and contributing to anaesthesia and pain medicin...
Find out more
Get involved in the college community
Find out how we can help you connect and collaborate with colleagues; build your professional networks; learn leadership skills; and develop your career as a specialist.
Find out more
ANZCA National Anaesthesia Day
Each year we celebrate ANZCA National Anaesthesia Day across Australia and New Zealand on 16 October, the anniversary of the day in 1846 that ether anaesthetic was first demonstrated in Boston, Massachusetts.
Find out more
Co-prescription of gabapentinoids and opioids
Following the death of a person after minor foot surgery, ANZCA reminds fellows that under certain conditions the interaction of gabapentinoids and opioids can cause severe respiratory depression, resulting in death.
Find out more